Amphastar Pharmaceuticals AMPH reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Amphastar Pharmaceuticals their estimated earnings by 91.67%, reporting an EPS of $0.46 versus an estimate of $0.24, which surprised analysts.
Revenue was up $28,767,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0, which was followed by a 1.2% increase in the share price the next day.
Here's a look at Amphastar Pharmaceuticals's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 0.21 | 0.18 | 0.14 | 0.14 |
EPS Actual | 0.21 | 0.27 | 0.16 | 0.15 |
Revenue Estimate | 101.78M | 97.26M | 88.94M | 91.26M |
Revenue Actual | 101.66M | 103.02M | 95.92M | 83.43M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.